Core Viewpoint - AI-assisted medical devices are at a critical juncture for large-scale hospital use, necessitating the establishment of a standardized system [1][3]. Group 1: Policy and Regulation - The document issued by the Central Committee and the State Council emphasizes the need for innovative support mechanisms for emerging industries, particularly in AI-assisted medical devices [1][3]. - The exploration of access and application mechanisms for AI-assisted medical devices is highlighted, focusing on data collection, integration, sharing, and compliance under safe and controllable conditions [1][4]. Group 2: Industry Trends - The healthcare sector is witnessing a deep transformation due to AI technologies, with numerous medical device companies collaborating with clinical institutions [3]. - Shenzhen is positioning itself as a pioneer city for AI innovation in healthcare, with nearly 450 real application scenarios being launched [3]. Group 3: Data Management - Data is identified as a key element in AI, becoming crucial for enhancing precision and iteration speed in AI applications [4][5]. - The need for rules and standards regarding data ownership, usage rights, and pricing transactions for AI medical devices is emphasized [5]. Group 4: Market Dynamics - The inclusion of AI-assisted diagnosis in the medical service pricing structure by the National Healthcare Security Administration indicates a shift in how hospitals can utilize AI in diagnostics [6]. - Despite the integration of AI into the pricing system, challenges remain regarding the establishment of unified pricing standards for AI medical devices [6].